Kyung Nam Pharm Co Ltd - Asset Resilience Ratio
Kyung Nam Pharm Co Ltd (053950) has an Asset Resilience Ratio of 17.53% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2007–2025)
This chart shows how Kyung Nam Pharm Co Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Kyung Nam Pharm Co Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Kyung Nam Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 053950 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩30.85 Billion | 17.53% |
| Total Liquid Assets | ₩30.85 Billion | 17.53% |
Asset Resilience Insights
- Good Liquidity Position: Kyung Nam Pharm Co Ltd maintains a healthy 17.53% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Kyung Nam Pharm Co Ltd Industry Peers by Asset Resilience Ratio
Compare Kyung Nam Pharm Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
| No industry peers found with asset resilience data. | ||
Annual Asset Resilience Ratio for Kyung Nam Pharm Co Ltd (2007–2025)
The table below shows the annual Asset Resilience Ratio data for Kyung Nam Pharm Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 28.84% | ₩44.89 Billion ≈ $30.42 Million |
₩155.63 Billion ≈ $105.47 Million |
+23.41pp |
| 2023-12-31 | 5.43% | ₩9.05 Billion ≈ $6.13 Million |
₩166.61 Billion ≈ $112.91 Million |
+3.64pp |
| 2022-12-31 | 1.80% | ₩2.49 Billion ≈ $1.68 Million |
₩138.27 Billion ≈ $93.70 Million |
-1.24pp |
| 2010-12-31 | 3.04% | ₩2.71 Billion ≈ $1.84 Million |
₩89.20 Billion ≈ $60.45 Million |
-2.29pp |
| 2009-12-31 | 5.33% | ₩4.88 Billion ≈ $3.31 Million |
₩91.51 Billion ≈ $62.01 Million |
-2.86pp |
| 2008-12-31 | 8.19% | ₩5.33 Billion ≈ $3.61 Million |
₩65.05 Billion ≈ $44.08 Million |
+1.14pp |
| 2007-12-31 | 7.05% | ₩3.27 Billion ≈ $2.22 Million |
₩46.40 Billion ≈ $31.44 Million |
-- |
About Kyung Nam Pharm Co Ltd
Kyung Nam Pharm Co.,Ltd. manufactures pharmaceuticals. The company offers over-the-counter products, including antipyretics, analgesics, and antiphlogistics; medications for skin diseases and athlete's foot; pain relief patches/creams, antitussives, mucolytic agents, and expectorants; gastro protective agents/digestives; periodontal/gum disease drugs; medications for liver diseases; ear and nose … Read more